by Kall Kwik WGC | Mar 12, 2009 | Free Library
February, 2006 SAI-046 From Data to Value This is a report of the Cranfield Customer Management Forum’s work in 2004/5. Few companies today would define themselves as anything other than knowledge-based. For knowledge-based marketers, the...
by Kall Kwik WGC | Mar 12, 2009 | Free Library
March, 2006 SMM-015 In Theory What should pharma marketers do when faced with the task of creating a successful international strategy with a new chemical entity that may not be a totally new, fully differentiated molecule? Clinging to industry...
by Kall Kwik WGC | Mar 12, 2009 | Free Library
March, 2006 SAI-014 The Money Pit Many marketing strategies destroy shareholder value instead of creating it. In this interview in The Marketer, Dr Brian Smith and his co-authors of Marketing Due Diligence discuss the causes and cures for this...
by Kall Kwik WGC | Mar 12, 2009 | Free Library
April, 2006 SMM-016 The Extra Mile We know that marketing excellence exists, so how are pharma companies expected to achieve it, and what are the differences between ‘normal’ and ‘excellent’ practices?
by Kall Kwik WGC | Mar 12, 2009 | Free Library
May, 2006 SAI-015 Easy as 1,2,3 There are three levels of marketing accountability and great marketers understand them all. Applying rigour at all three levels is what distinguishes a great marketing company from the less...
